Join to View Full Profile
101 The City Dr SLos Angeles, CA 92868
Phone+1 323-442-1946
Fax+1 323-442-2874
Dr. Stohl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1979 - 1982
Perelman School of Medicine at the University of PennsylvaniaClass of 1977
Certifications & Licensure
CA State Medical License 1986 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow American College of Rheumatology
Clinical Trials
- Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs Start of enrollment: 2021 Mar 22
Publications & Presentations
PubMed
- Contributions of each of the BAFF receptors to the lymphocyte profiles in C57BL/6 mice.William Stohl, Ying Wu, Malka Stohl
Immunology. 2024-12-01 - BAFF promotes follicular helper T cell development and germinal center formation through BR3 signal.Ye Chen, Maogen Chen, Yu Liu, Qiang Li, Youqiu Xue
JCI Insight. 2024-11-08 - 1 citationsT cell Dissimilarities in B Cell Activating Factor-Deficient Versus B Cell Activating Factor Receptor 3-Deficient Systemic Lupus Erythematosus-Prone NZM 2328 Mice as C...William Stohl, Ying Wu, Malka Stohl
ACR Open Rheumatology. 2024-11-01
Press Mentions
Combo Biologic Therapy Makes Good in SLEOctober 26th, 2021- 2 Cases of SLE-Associated Diffuse Alveolar HemorrageAugust 12th, 2021
- COVID-19 Vaccines: Safe for Immunocompromised Patients?December 17th, 2020
- Join now to see all
Grant Support
- The Vital Role Of BAFF In The Development Of SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2010
- A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Ranging StudyNational Center For Research Resources2005–2008
- T Cell Cytolytic Activity In SLENational Center For Research Resources1999–2002
- T Cell Cytolytic Activity In SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases1997–2000
- T-Cell Cytolytic Activity In SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases1993–1995
- Polymorphism Within T4/Leu3 And SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases1987–1988
- Polymorphism Within T4/Leu3 And SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases1986
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
